What urine albumin‑creatinine ratio (UACR) values determine eligibility for a prospective kidney transplant donor?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Kidney Transplant Donor Urine Albumin-Creatinine Ratio Eligibility Criteria

Prospective kidney donors with albumin excretion rate (AER) less than 30 mg/day are acceptable for donation, those with AER 30-100 mg/day require individualized risk assessment based on their demographic and health profile, and those with AER greater than 100 mg/day should be excluded from donation. 1

Screening Protocol

Initial Testing

  • Screen all donor candidates using a random (untimed) spot urine albumin-to-creatinine ratio (UACR/ACR). 1
  • The first morning void is preferred when possible, though any random specimen is acceptable. 2

Confirmation of Abnormal Results

If the initial UACR is elevated, confirm with one of the following:

  • Albumin excretion rate (AER) measured in a 24-hour timed urine collection (preferred method) 1
  • Repeat UACR if timed collection cannot be obtained 1

Eligibility Thresholds Based on Confirmed AER

Acceptable for Donation

  • AER < 30 mg/day: These candidates are acceptable for kidney donation without additional concerns regarding albuminuria. 1

Gray Zone Requiring Risk Assessment

  • AER 30-100 mg/day: Approval depends on the transplant program's risk threshold and the candidate's complete profile including age, comorbidities, family history, and other risk factors for future chronic kidney disease. 1
  • Research shows that even donors with preoperative UACR in the normal range but at higher levels may have increased postoperative albuminuria and delayed renal function recovery. 3

Exclusion from Donation

  • AER > 100 mg/day: These candidates should not donate kidneys. 1

Important Clinical Considerations

Factors That Can Transiently Elevate UACR

Ensure testing is not performed when the following conditions are present, as they can cause false elevations: 2

  • Exercise within 24 hours
  • Active urinary tract infection or fever
  • Congestive heart failure
  • Marked hyperglycemia
  • Menstruation
  • Severe uncontrolled hypertension

Additional Testing Recommendation

While KDIGO guidelines recommend measuring only albuminuria, UNOS policy requires measurement of both total urine protein and urine albumin. 1 This dual approach can identify non-albumin proteinuria that may indicate tubular defects, tubulointerstitial disease, or paraproteinemia that could lead to future chronic kidney disease. 1

Prognostic Value

Even within the normoalbuminuric range (UACR < 30 mg/g), higher baseline albuminuria levels correlate with increased risk of chronic kidney disease progression. 4 Donors with higher preoperative UACR—even within normal limits—demonstrate persistently elevated postoperative UACR and are associated with histological abnormalities on implantation biopsy. 3

Common Pitfalls to Avoid

  • Do not rely on urine dipstick alone for albuminuria screening, as it lacks sensitivity for detecting moderate albuminuria (30-300 mg/g). 2
  • Do not dismiss post-donation proteinuria as simply a consequence of donation; it warrants complete workup as in the general population, since kidney donors have a ~12% incidence of post-donation proteinuria. 1
  • Do not use a single UACR measurement to make final decisions in borderline cases, given the high biological variability (coefficient of variation ~49%). 5

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.